Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug safety

Showing results (1-10 of 3,507) with videos related to

Pageof 351
Sort By:
Drug Safety|July 5, 2022
Short-Term Risk of Unintentional Poisoning After New Initiation of Central Nervous System Medications in Swedish Older Adults: A Register-Based Case-Crossover StudyYang Zhao, Yajun Liang, Lucie Laflamme, et al.
Drug Safety|October 26, 2020
Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin CancerJulie Rouette, Hui Yin, Anton Pottegård, et al.
Drug Safety|September 12, 2020
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)Hugo Arlegui, Kaatje Bollaerts, Vincent Bauchau, et al.
Drug Safety|August 12, 2023
Comment on: "Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System"Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, et al.
Drug Safety|November 27, 2020
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19Catia Marzolini, Felix Stader, Anne Leuppi-Taegtmeyer, et al.
Drug Safety|October 4, 2020
Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-ReportingBjörn Koneswarakantha, Yves Barmaz, Timothé Ménard, et al.
Drug Safety|October 9, 2020
Liver Injury Associated with the Selective Progesterone Modulator UlipristalEinar S Björnsson
Drug Safety|January 15, 2023
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based StudyShuang Wang, Kimford J Meador, Jayne Pawasauskas, et al.
Drug Safety|December 20, 2022
Should Antidepressants be Avoided in Pregnancy?Frank M C Besag, Michael J Vasey
Drug Safety|May 31, 2022
Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced NephrotoxicityXiao Wei, Jun Yu, Zhengkun Xu, et al.
Pageof 351

Showing results (1-10 of 3,507) with videos related to

Sort By:
Pageof 351
Drug Safety|July 5, 2022
Short-Term Risk of Unintentional Poisoning After New Initiation of Central Nervous System Medications in Swedish Older Adults: A Register-Based Case-Crossover StudyYang Zhao, Yajun Liang, Lucie Laflamme, et al.
Drug Safety|October 26, 2020
Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin CancerJulie Rouette, Hui Yin, Anton Pottegård, et al.
Drug Safety|September 12, 2020
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)Hugo Arlegui, Kaatje Bollaerts, Vincent Bauchau, et al.
Drug Safety|August 12, 2023
Comment on: "Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System"Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, et al.
Drug Safety|November 27, 2020
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19Catia Marzolini, Felix Stader, Anne Leuppi-Taegtmeyer, et al.
Drug Safety|October 4, 2020
Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-ReportingBjörn Koneswarakantha, Yves Barmaz, Timothé Ménard, et al.
Drug Safety|October 9, 2020
Liver Injury Associated with the Selective Progesterone Modulator UlipristalEinar S Björnsson
Drug Safety|January 15, 2023
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based StudyShuang Wang, Kimford J Meador, Jayne Pawasauskas, et al.
Drug Safety|December 20, 2022
Should Antidepressants be Avoided in Pregnancy?Frank M C Besag, Michael J Vasey
Drug Safety|May 31, 2022
Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced NephrotoxicityXiao Wei, Jun Yu, Zhengkun Xu, et al.
Pageof 351